Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (781-790 of 839) with videos related to

Pageof 84
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 11, 2022
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinomaEmily Chan, Jesse K McKenney, Sarah Hawley, et al.
Nucleic Acids Research|December 19, 2022
Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expressionFan Zhang, Maitree Biswas, Shabnam Massah, et al.
European Urology|December 21, 2017
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants MeetingJun Luo, Gerhardt Attard, Steven P Balk, et al.
Trends in Ecology & Evolution|December 9, 2017
A 2018 Horizon Scan of Emerging Issues for Global Conservation and Biological DiversityWilliam J Sutherland, Stuart H M Butchart, Ben Connor, et al.
Nature Communications|May 5, 2018
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progressionDiego Farinello, Monika Wozińska, Elisa Lenti, et al.
Human Pathology|February 17, 2022
Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosisSamuel Ruder, Yan Gao, Yi Ding, et al.
Advances in Anatomic Pathology|December 13, 2012
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue MicroarraySarah Hawley, Ladan Fazli, Jesse K McKenney, et al.
Genome Biology|August 27, 2014
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancerAlexander W Wyatt, Fan Mo, Kendric Wang, et al.
Nature Cell Biology|September 7, 2021
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancerAlastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2008
BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cellsPaul Beswick, Nicolas Charrier, Brian Clarke, et al.
Pageof 84

Showing results (781-790 of 839) with videos related to

Sort By:
Pageof 84
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 11, 2022
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinomaEmily Chan, Jesse K McKenney, Sarah Hawley, et al.
Nucleic Acids Research|December 19, 2022
Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expressionFan Zhang, Maitree Biswas, Shabnam Massah, et al.
European Urology|December 21, 2017
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants MeetingJun Luo, Gerhardt Attard, Steven P Balk, et al.
Trends in Ecology & Evolution|December 9, 2017
A 2018 Horizon Scan of Emerging Issues for Global Conservation and Biological DiversityWilliam J Sutherland, Stuart H M Butchart, Ben Connor, et al.
Nature Communications|May 5, 2018
A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progressionDiego Farinello, Monika Wozińska, Elisa Lenti, et al.
Human Pathology|February 17, 2022
Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosisSamuel Ruder, Yan Gao, Yi Ding, et al.
Advances in Anatomic Pathology|December 13, 2012
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue MicroarraySarah Hawley, Ladan Fazli, Jesse K McKenney, et al.
Genome Biology|August 27, 2014
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancerAlexander W Wyatt, Fan Mo, Kendric Wang, et al.
Nature Cell Biology|September 7, 2021
An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancerAlastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2008
BACE-1 inhibitors part 3: identification of hydroxy ethylamines (HEAs) with nanomolar potency in cellsPaul Beswick, Nicolas Charrier, Brian Clarke, et al.
Pageof 84